Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xencor Inc (XNCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,534,124
  • Shares Outstanding, K 55,830
  • Annual Sales, $ 35,710 K
  • Annual Income, $ -48,930 K
  • 36-Month Beta 1.61
  • Price/Sales 70.44
  • Price/Cash Flow N/A
  • Price/Book 4.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.56
  • Number of Estimates 3
  • High Estimate -0.50
  • Low Estimate -0.64
  • Prior Year -0.33
  • Growth Rate Est. (year over year) -69.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.28 +21.97%
on 09/07/18
48.38 -6.01%
on 09/14/18
+4.48 (+10.93%)
since 08/21/18
3-Month
34.94 +30.14%
on 07/30/18
48.38 -6.01%
on 09/14/18
+5.54 (+13.87%)
since 06/21/18
52-Week
18.97 +139.69%
on 11/02/17
48.38 -6.01%
on 09/14/18
+23.33 (+105.37%)
since 09/21/17

Most Recent Stories

More News
Xencor Reaches Analyst Target Price

In recent trading, shares of Xencor, Inc have crossed above the average analyst 12-month target price of $44.83, changing hands for $45.65/share. When a stock reaches the target an analyst has set, the...

XNCR : 45.35 (-0.09%)
New Research Coverage Highlights Goldman Sachs BDC, PTC, Weingarten Realty Investors, Astronics, Xencor, and Chemours -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Goldman Sachs BDC, Inc. (NYSE:GSBD),...

CC : 41.60 (+0.12%)
XNCR : 45.35 (-0.09%)
PTC : 104.58 (+1.47%)
ATRO : 43.80 (+1.25%)
GSBD : 22.40 (+0.13%)
WRI : 29.83 (+0.37%)
Xencor (XNCR) Reports Q2 Loss, Misses Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of 16.36% and -100.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

XNCR : 45.35 (-0.09%)
Xencor: 2Q Earnings Snapshot

MONROVIA, Calif. (AP) _ Xencor Inc. (XNCR) on Monday reported a loss of $25.9 million in its second quarter.

XNCR : 45.35 (-0.09%)
Xencor, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 6, 2018 / Xencor, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 6, 2018 at 4:30 PM Eastern Time.

XNCR : 45.35 (-0.09%)
Xencor to Host Second Quarter 2018 Financial Results Webcast and Conference Call on August 6, 2018

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases and cancer, announced...

XNCR : 45.35 (-0.09%)
XNCR Crosses Above Average Analyst Target

In recent trading, shares of Xencor, Inc have crossed above the average analyst 12-month target price of $42.00, changing hands for $42.31/share. When a stock reaches the target an analyst has set, the...

XNCR : 45.35 (-0.09%)
Kodiak Sciences Appoints Bassil I. Dahiyat, Ph.D. Robert A. Profusek, J.D. and Richard S. Levy, M.D. to its Board of Directors

Kodiak Sciences Inc., a clinical stage biopharmaceutical company specializing in novel therapeutics to treat high prevalence ophthalmic diseases, today announced the appointments of Bassil I. Dahiyat,...

CTS : 36.55 (-0.27%)
VLO : 112.06 (+1.43%)
XNCR : 45.35 (-0.09%)
Xencor Inc Shares Up 29.5% Since SmarTrend's Buy Recommendation (XNCR)

SmarTrend identified an Uptrend for Xencor Inc (NASDAQ:XNCR) on May 14th, 2018 at $32.16. In approximately 1 month, Xencor Inc has returned 29.47% as of today's recent price of $41.63.

XNCR : 45.35 (-0.09%)
Xencor: 1Q Earnings Snapshot

MONROVIA, Calif. (AP) _ Xencor Inc. (XNCR) on Monday reported a loss of $29.5 million in its first quarter.

XNCR : 45.35 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade XNCR with:

Business Summary

Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.

See More

Key Turning Points

2nd Resistance Point 47.28
1st Resistance Point 46.33
Last Price 45.35
1st Support Level 44.76
2nd Support Level 44.14

See More

52-Week High 48.38
Last Price 45.35
Fibonacci 61.8% 37.15
Fibonacci 50% 33.67
Fibonacci 38.2% 30.20
52-Week Low 18.97

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar